Lurasidone

Lurasidone, sold under the brand name Latuda, is a medication. It is an atypical antipsychotic medication that is used to treat schizophrenia and bipolar depression. It is taken by mouth. It was first approved for medical use in the United States in 2010. In 2013, it was approved in Canada and by the U.S. Food and Drug Administration (FDA) to treat bipolar depression.


This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.